Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000296672 is an uncharacterized long non-coding RNA that lies antisense to the PHGDH locus. PHGDH encodes the enzyme 3-phosphoglycerate dehydrogenase, which catalyzes the first step in the serine biosynthesis pathway and has implications in cancer resistance[3][1]. However, the biological significance of this antisense RNA transcript remains unstudied; it is catalogued in functional genomics repositories such as Ensembl and GeneCards but lacks experimentally validated attributes, aliases, or any connection to canonical protein targets or therapeutic agents[5]. It is not a canonical receptor, enzyme, transporter, transcription factor, or any other characterized target class. For drug discovery, this transcript should not be considered a validated molecular target. ENSG00000296672 represents a non-coding RNA, not a protein-coding gene or therapeutic target. Its “target” status is incorrect for drug discovery or target annotation. No aliases, functional classification, disease association, or drug interaction data are available[5]. For structured databases and curation, use the canonical information for PHGDH and disregard this transcript unless future research validates functional or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to PHGDH.